Method of preventive treatment of allergy by mucosal administration of an allergy vaccine

A technology for allergic reactions and treatment methods, applied in the direction of allergen antigen components, etc., can solve life-threatening problems, and achieve the effect of alleviating allergic symptoms and medical consumption

Inactive Publication Date: 2007-10-31
ALK ABELLO SA
View PDF14 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

After each injection, the patient must be under medical supervision for 30 minutes because of the risk of allergic side reactions, which, although extremely rare, can in principle be life-threatening

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method of preventive treatment of allergy by mucosal administration of an allergy vaccine
  • Method of preventive treatment of allergy by mucosal administration of an allergy vaccine
  • Method of preventive treatment of allergy by mucosal administration of an allergy vaccine

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0115] Example 1: The effect of SLIT on a mouse model of rhinitis

[0116] Fundamental:

[0117] A rhinitis model was established to test the effect of sublingual immunotherapy (SLIT) in a clinically manifested mouse model.

[0118] method:

[0119] animal

[0120] 6-10 week old female BALB / c mice are housed and maintained on a specific diet that does not contain components that can cross-react with antiserum to Timothy grass (Phl p). Each experimental group included 8-10 animals.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention relates to a method of preventive treatment of allergy to an allergen in a subject comprising administering an allergy vaccine containing the allergen as active substance to a mucosal surface of the subject, a) wherein the subject to be treated is sensitised so as to exhibit an IgE response specific to the allergen, b) wherein the subject to be treated is free of clinical symptoms of the allergy associated with the allergen, and c) wherein the preventive treatment is aimed at preventing or reducing subsequent clinical symptoms of the allergy associated with the allergen.

Description

field of invention [0001] The present invention relates to a method of prophylactically treating an allergic reaction to an allergen in a subject comprising administering anaphylaxis vaccine to a mucosal surface of the subject. Background of the invention [0002] Allergic reactions are a major health problem in countries adopting a Western lifestyle. In addition, the prevalence of allergic diseases is increasing in these countries. Although in general, anaphylaxis is not considered a life-threatening condition, asthma is responsible for a large number of deaths each year. The prevalence of the disorder in about 30% among adolescents results in a significant reduction in quality of life, workday and money, and constitutes a major type of health problem in the Western world. [0003] Anaphylaxis is a complex disease. Allergic events are caused by a variety of factors, including an individual's susceptibility determined by the not-well-understood interplay of several genes....

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K39/35
Inventor J·布里莫奈斯J·基尔德斯加德
Owner ALK ABELLO SA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products